ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2021

Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis.

Adham Fani Maleki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.